In a historic medical breakthrough, Northwestern Medicine surgeons successfully split a deceased donor’s liver to save two ...
M. Michele Blackwood, MD, FACS, highlights an innovative trial delivering 1 week of pre-surgery and 2 weeks of post-surgery ...
Baird Medical's AI Tumor Ablation Surgical Robot will be an intelligent surgical system that seamlessly integrates multimodal AI algorithms with high-precision robotic arm control. Its key innovations ...
Innovent Biologics’ Sycume receives China NMPA approval for treatment of thyroid eye disease: San Francisco Monday, March 17, 2025, 16:00 Hrs [IST] Innovent Biologics, Inc, a wo ...
6 天
WRIC ABC 8News on MSNUVA Health offers hope for some Virginians battling advanced abdominal cancersHealth is offering a new lifeline to some Virginians battling advanced abdominal cancers, providing access to a procedure ...
A recent study revealed a direct correlation between cumulative smoking exposure (CSE) and poorer oncologic outcomes in ...
CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...
Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of ...
Explore the Cancer Vaccines Market size, share, trends, and growth forecast. Learn about key industry players, advancements, and future opportunities in oncology ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...
Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study "Oncologic Outcomes of Blue Light Cystoscopy in an Equal ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果